Annual Operating Expenses
$68.86 M
+$17.66 M+34.50%
December 31, 2023
Summary
- As of February 8, 2025, JSPR annual total operating expenses is $68.86 million, with the most recent change of +$17.66 million (+34.50%) on December 31, 2023.
- During the last 3 years, JSPR annual operating expenses has risen by +$48.18 million (+232.94%).
- JSPR annual operating expenses is now at all-time high.
Performance
JSPR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$19.89 M
+$3.90 M+24.36%
September 30, 2024
Summary
- As of February 8, 2025, JSPR quarterly total operating expenses is $19.89 million, with the most recent change of +$3.90 million (+24.36%) on September 30, 2024.
- Over the past year, JSPR quarterly operating expenses has increased by +$527.00 thousand (+2.72%).
- JSPR quarterly operating expenses is now at all-time high.
Performance
JSPR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
JSPR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.5% | +2.7% |
| 3 y3 years | +232.9% | +2.7% |
| 5 y5 years | +232.9% | +2.7% |
JSPR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.0% | at high | +66.3% |
| 5 y | 5-year | at high | +232.9% | at high | +233.8% |
| alltime | all time | at high | +232.9% | at high | +233.8% |
Jasper Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.89 M(+24.4%) |
| Jun 2024 | - | $15.99 M(+6.1%) |
| Mar 2024 | - | $15.07 M(-15.0%) |
| Dec 2023 | $68.86 M(+34.5%) | $17.73 M(-8.5%) |
| Sep 2023 | - | $19.36 M(+8.6%) |
| Jun 2023 | - | $17.83 M(+27.8%) |
| Mar 2023 | - | $13.95 M(+1.5%) |
| Dec 2022 | $51.20 M | $13.75 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $12.71 M(+6.2%) |
| Jun 2022 | - | $11.96 M(-6.4%) |
| Mar 2022 | - | $12.78 M(+5.8%) |
| Dec 2021 | $36.83 M(+78.1%) | $12.08 M(+19.9%) |
| Sep 2021 | - | $10.08 M(+19.7%) |
| Jun 2021 | - | $8.42 M(+34.6%) |
| Mar 2021 | - | $6.25 M(+5.0%) |
| Dec 2020 | $20.68 M | $5.96 M(-0.8%) |
| Sep 2020 | - | $6.01 M |
FAQ
- What is Jasper Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Jasper Therapeutics?
- What is Jasper Therapeutics annual operating expenses year-on-year change?
- What is Jasper Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly operating expenses year-on-year change?
What is Jasper Therapeutics annual total operating expenses?
The current annual operating expenses of JSPR is $68.86 M
What is the all time high annual operating expenses for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total operating expenses is $68.86 M
What is Jasper Therapeutics annual operating expenses year-on-year change?
Over the past year, JSPR annual total operating expenses has changed by +$17.66 M (+34.50%)
What is Jasper Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of JSPR is $19.89 M
What is the all time high quarterly operating expenses for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total operating expenses is $19.89 M
What is Jasper Therapeutics quarterly operating expenses year-on-year change?
Over the past year, JSPR quarterly total operating expenses has changed by +$527.00 K (+2.72%)